The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Open accessAbstract
BACKGROUND: The optimal time for the initiation of antiretroviral therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection is uncertain. METHODS: We conducted two parallel analyses involving a total of 17,517 asymptomatic patients with HIV infection in the United States and Canada who received medical care during the period from 1996 through 2005. None of the patients had undergone previous antiretroviral therapy. In each group, we stratified the patients according to the CD4+ count (351 to 500 cells per cubic millimeter or >500 cells per cubic millimeter) at the initiation of antiretroviral therapy. In each group, we compared the relative risk of death for patients who initiated therapy when the CD4+ count was above each of the two thresholds of interest (early-therapy group) with that of patients who deferred therapy until the CD4+ count fell below these thresholds (deferred-therapy group). RESULTS: In the first analysis, which involved 8362 patients, 2084 (25%) initiated therapy at a CD4+ count of 351 to 500 cells per cubic millimeter, and 6278 (75%) deferred therapy. After adjustment for calendar year, cohort of patients, and demographic and clinical characteristics, among patients in the deferred-therapy group there was an increase in the risk of death of 69%, as compared with that in the early-therapy group (relative risk in the deferred-therapy group, 1.69; 95% confidence interval [CI], 1.26 to 2.26; P<0.001). In the second analysis involving 9155 patients, 2220 (24%) initiated therapy at a CD4+ count of more than 500 cells per cubic millimeter and 6935 (76%) deferred therapy. Among patients in the deferred-therapy group, there was an increase in the risk of death of 94% (relative risk, 1.94; 95% CI, 1.37 to 2.79; P<0.001). CONCLUSIONS: The early initiation of antiretroviral therapy before the CD4+ count fell below two prespecified thresholds significantly improved survival, as compared with deferred therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
Castro, K. G., Ward, J. W., Slutsker, L., Buehler, J. W., Jaffe, H. W., Berkelman, R. L., & Curran, J. W. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.802 · Cited by 4,349
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Self-citationAdherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00004 · Cited by 3,289
Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,469
Self-citationRosenbaum, P. R. (2002) · Springer Series in Statistics · doi:10.1007/978-1-4757-3692-2 · Cited by 2,394
Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D. J., & Cooper, D. A. (1998) · AIDS · doi:10.1097/00002030-199807000-00003 · Cited by 2,370
CD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection
Mellors, J. W., Munoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., Kingsley, L. A., Todd, J. A., Saah, A. J., Detels, R., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00003 · Cited by 2,067
Cited by
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Self-citationTiming of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
Abdool Karim, S. S., Naidoo, K., Grobler, A., Padayatchi, N., Baxter, C., Gray, A., Gengiah, T., Nair, G., Bamber, S., Singh, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905848 · Cited by 666
Günthard, H. F., Saag, M. S., Benson, C. A., del Rio, C., Eron, J. J., Gallant, J. E., Hoy, J. F., Mugavero, M. J., Sax, P. E., Thompson, M. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.8900 · Cited by 656
Self-citation(2010) · Clinical Infectious Diseases · doi:10.1086/652283 · Cited by 594
Grinsztejn, B., Hosseinipour, M. C., Ribaudo, H. J., Swindells, S., Eron, J., Chen, Y. Q., Wang, L., Ou, S.-S., Anderson, M., McCauley, M., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70692-3 · Cited by 494
Self-citationGeneralizing Evidence From Randomized Clinical Trials to Target Populations: The ACTG 320 Trial
Cole, S. R., & Stuart, E. A. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq084 · Cited by 486
Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-1-201307020-00645 · Cited by 393
Successes and challenges of HIV prevention in men who have sex with men
Sullivan, P. S., Carballo-Diéguez, A., Coates, T., Goodreau, S. M., McGowan, I., Sanders, E. J., Smith, A., Goswami, P., & Sanchez, J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60955-6 · Cited by 382
Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti
Severe, P., Jean Juste, M. A., Ambroise, A., Eliacin, L., Marchand, C., Apollon, S., Edwards, A., Bang, H., Nicotera, J., Godfrey, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910370 · Cited by 377
Barriers to HIV testing in Europe: a systematic review
Deblonde, J., De Koker, P., Hamers, F. F., Fontaine, J., Luchters, S., & Temmerman, M. (2010) · The European Journal of Public Health · doi:10.1093/eurpub/ckp231 · Cited by 357
Food Insecurity as a Barrier to Sustained Antiretroviral Therapy Adherence in Uganda
Weiser, S. D., Tuller, D. M., Frongillo, E. A., Senkungu, J., Mukiibi, N., & Bangsberg, D. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010340 · Cited by 321
HIV and aging: time for a new paradigm.
Justice, A. C. (2010) · Current HIV/AIDS Reports · doi:10.1007/s11904-010-0041-9 · Cited by 309
Self-citationSecondary immunodeficiencies, including HIV infection
Chinen, J., & Shearer, W. T. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.08.040 · Cited by 305
HIV treatment as prevention and HPTN 052
Cohen, M. S., McCauley, M., & Gamble, T. R. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32834f5cf2 · Cited by 301
Regression Discontinuity Designs in Epidemiology: Causal Inference Without Randomized Trials
Bor, J., Moscoe, E., Mutevedzi, P., Newell, M.-L., & Bärnighausen, T. (2014) · Epidemiology · doi:10.1097/ede.0000000000000138 · Cited by 291
Cohort Profile: The Women’s Interagency HIV Study (WIHS)
Adimora, A. A., Ramirez, C., Benning, L., Greenblatt, R. M., Kempf, M.-C., Tien, P. C., Kassaye, S. G., Anastos, K., Cohen, M., Minkoff, H., et al. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy021 · Cited by 298
Self-citationHIV prevention transformed: the new prevention research agenda
Padian, N. S., McCoy, S. I., Karim, S. S. A., Hasen, N., Kim, J., Bartos, M., Katabira, E., Bertozzi, S. M., Schwartländer, B., & Cohen, M. S. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60877-5 · Cited by 295
HIV Infection, Immunodeficiency, Viral Replication, and the Risk of Cancer
Silverberg, M. J., Chao, C., Leyden, W. A., Xu, L., Horberg, M. A., Klein, D., Towner, W. J., Dubrow, R., Quesenberry, C. P., Neugebauer, R. S., et al. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0777 · Cited by 294
Self-citation. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.
Tien, P. C., Choi, A. I., Zolopa, A. R., Benson, C., Tracy, R., Scherzer, R., Bacchetti, P., Shlipak, M., & Grunfeld, C. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181e66216 · Cited by 279
Current status and challenges of antiretroviral research and therapy
Esté, J. A., & Cihlar, T. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.007 · Cited by 277
Universal Voluntary Testing and Treatment for Prevention of HIV Transmission
Dieffenbach, C. W. (2009) · JAMA · doi:10.1001/jama.2009.828 · Cited by 269
Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans
Womack, J. A., Goulet, J. L., Gibert, C., Brandt, C., Chang, C. C., Gulanski, B., Fraenkel, L., Mattocks, K., Rimland, D., Rodriguez-Barradas, M. C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017217 · Cited by 261
Self-citationGupta, A., Nadkarni, G., Yang, W.-T., Chandrasekhar, A., Gupte, N., Bisson, G. P., Hosseinipour, M., & Gummadi, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028691 · Cited by 254
Farnham, P. G., Gopalappa, C., Sansom, S. L., Hutchinson, A. B., Brooks, J. T., Weidle, P. J., Marconi, V. C., & Rimland, D. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182973966 · Cited by 129
Self-citationGreen, T. C., Kershaw, T., Lin, H., Heimer, R., Goulet, J. L., Kraemer, K. L., Gordon, A. J., Maisto, S. A., Day, N. L., Bryant, K., et al. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.02.020 · Cited by 101
Self-citationMehta, S. H., Lucas, G. M., Solomon, S., Srikrishnan, A. K., McFall, A. M., Dhingra, N., Nandagopal, P., Kumar, M. S., Celentano, D. D., & Solomon, S. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ669 · Cited by 67
Nsanzimana, S., Ruton, H., Lowrance, D. W., Cishahayo, S., Nyemazi, J. P., Muhayimpundu, R., Karema, C., Raghunathan, P. L., Binagwaho, A., & Riedel, D. J. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31823e2278 · Cited by 48
Chou, R., Selph, S., Dana, T., Bougatsos, C., Zakher, B., Blazina, I., & Korthuis, P. T. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-10-201211200-00007 · Cited by 46
Seth, P., Wang, G., Sizemore, E., & Hogben, M. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302778 · Cited by 12
Healthcare Costs Associated with Antiretroviral Adherence Among Medicaid Patients
Pruitt, Z., Robst, J., Langland-Orban, B., & Brooks, R. G. (2015) · Applied Health Economics and Health Policy · doi:10.1007/s40258-014-0138-1 · Cited by 11
Metadata
- Authors
- Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., Hogg, R. S., Deeks, S. G., Eron, J. J., Brooks, J. T., Rourke, S. B., Gill, M. J., Bosch, R. J., Martin, J. N., Klein, M. B., Jacobson, L. P., Rodriguez, B., Sterling, T. R., Kirk, G. D., Napravnik, S., Rachlis, A. R., Calzavara, L. M., Horberg, M. A., Silverberg, M. J., Gebo, K. A., Goedert, J. J., Benson, C. A., Collier, A. C., Van Rompaey, S. E., Crane, H. M., McKaig, R. G., Lau, B., Freeman, A. M., & Moore, R. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-04-30
- Volume
- 360
- Issue
- 18
- Pages
- 1815-1826
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2143265231
- Cited by
- 1,105
- References
- 56
- FWCI
- 100.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.